Quoin Pharmaceuticals QNRX Balance Sheet (2017-2026)

NASDAQ QNRX
$6.97 -0.18 (-2.52%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Quoin Pharmaceuticals Quarterly Balance Sheet

Periods 27 quarters
Latest Jun 2026

Quoin Pharmaceuticals reported total assets of $11.97M and total liabilities of $8.04M for the quarter ended Jun 2026, up 34.3% year over year. This balance sheet covers 27 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2017 Jun2018 Dec2018 Jun2019 Jun2020 Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
7.48M2.69M5.25M2.86M3.40M4.80M3.20M2.40M1.83M2.85M3.12M3.62M3.82M1.70M1.83M3.82M3.12M3.85M
Receivables - NetNet Receivables
Receivables - OtherOther Receivables
1.96M1.90M1.80M1.70M1.66M1.60M1.50M1.40M
Receivables
Prepaid Assets
0.72M0.83M0.50M0.52M0.40M0.23M0.16M0.59M0.57M0.65M0.19M0.87M0.94M0.69M0.60M1.26M1.29M0.84M
Current Assets
8.20M3.51M15.66M13.37M17.39M15.67M14.14M11.29M15.26M13.22M10.50M14.93M12.50M8.48M6.02M20.01M15.33M11.64M
Non-Current Assets
Property, Plant & Equipment (Net)
Long-Term Investments
9.91M9.99M13.62M10.70M10.82M8.29M12.90M9.73M7.20M10.43M7.73M6.12M3.60M
Intangibles
0.81M0.76M0.73M0.70M0.68M0.65M0.63M0.58M0.56M0.53M0.51M0.48M0.46M0.43M0.41M1.00M1.00M1.00M
Goodwill & Intangibles
0.81M0.76M0.73M0.70M0.68M0.65M0.63M0.58M0.56M0.53M0.51M0.48M0.46M0.43M0.41M1.00M1.00M1.00M
Other Non-Current Assets
0.30M0.05M0.05M0.38M0.38M0.38M0.30M0.30M0.30M0.30M0.38M0.30M
Non-Current Assets
1.16M0.81M0.78M1.09M1.06M1.04M0.93M0.88M0.86M0.83M0.89M0.78M0.46M0.43M0.41M0.38M0.36M0.33M
Assets
9.36M4.32M16.44M14.46M18.45M16.71M15.07M12.17M16.12M14.05M11.39M15.71M12.96M8.91M6.42M20.39M15.69M11.97M
Liabilities
Current Liabilities
Accounts Payables
0.92M0.77M0.28M0.61M0.28M0.71M0.24M0.53M0.36M0.82M0.22M0.91M0.64M0.87M1.86M1.26M1.78M3.11M
Notes Payables
0.60M4.42M4.27M4.12M4.02M
Payables
1.52M5.19M4.55M4.73M4.30M0.71M0.24M0.53M0.36M0.82M0.22M0.91M0.64M0.87M1.86M1.26M1.78M3.11M
Accumulated Expenses
1.69M1.86M1.57M1.18M2.09M1.83M2.59M1.31M2.12M1.39M1.50M1.53M2.47M1.72M2.16M2.54M1.82M1.76M
Other Accumulated Expenses
0.01M0.04M0.06M0.60M0.12M0.72M0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M
Total Current Liabilities
4.58M3.67M3.60M3.53M4.16M4.41M4.58M3.58M4.22M3.95M3.47M4.18M4.86M4.34M5.76M5.55M5.35M6.61M
Non-Current Liabilities
Non-Current Debt
4.12M3.52M
Operating Leases
Other Non-Current Liabilities
0.37M2.20M9.91M4.12M3.95M3.67M2.92M3.37M3.22M2.47M2.92M2.17M2.02M1.87M2.32M2.17M2.02M
Total Non-Current Liabilities
8.33M5.29M-2.64M2.93M3.69M3.98M3.58M3.62M3.35M3.47M3.58M4.86M4.34M5.76M4.95M4.75M6.01M
Total Liabilities
16.25M8.70M0.73M7.49M7.27M7.05M7.54M7.64M7.65M6.51M7.00M6.58M5.95M6.50M7.03M6.36M7.64M7.27M6.92M8.04M
Shareholder's Equity
Total Debt
4.72M4.42M4.27M7.65M4.02M
Common Equity
-16.25M0.66M-0.73M-3.17M9.17M7.41M10.91M9.07M7.41M5.66M9.13M7.48M5.44M9.20M5.93M2.55M-1.21M13.12M8.77M3.93M
Liabilities and Shareholders Equity
9.36M4.32M16.44M14.46M18.45M16.71M15.07M12.17M16.12M14.05M11.39M15.71M12.96M8.91M6.42M20.39M15.69M11.97M
Treasury Shares
2.93M2.93M2.93M2.93M2.93M2.93M2.93M
Retained Earnings
31.66M-32.42M47.62M47.86M53.97M54.23M54.50M51.87M57.66M57.98M58.30M64.37M64.90M65.23M-66.62M84.09M84.74M85.27M